EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Plant‐Derived Natural Product Nanodelivery System in Cancer Therapy

Changqi Shi, LuLu Zhang, Lan Yan, Qi Geng iD, Li Li, Xiaojuan He iD, Ning Zhao, Yong Tan, Xiaomeng Zhang, Cheng Lu iD

Phytotherapy Research · 2026-11 · 40 (11) · 6644-6669

DOI: 10.1002/ptr.70441 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2026-09-20. Written by Changqi Shi and 9 co-authors. Institution: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Major MEDLINE topics: Biological Products, Neoplasms, Antineoplastic Agents, Drug Delivery Systems. 172 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Plant‐derived natural products have emerged as important sources of anticancer agents because of their diverse chemical structures and broad biological activities. However, their clinical application is often limited by poor aqueous solubility, low membrane permeability, insufficient tumor selectivity, and systemic toxicity. Recent advances in nanodelivery systems have provided effective strategies to overcome these pharmacokinetic and pharmacodynamic barriers by improving drug stability, enhancing tumor‐targeted accumulation, and promoting intracellular delivery. In this review, we systematically summarise recent progress in the nanotechnology‐based delivery of plant‐derived natural products for cancer therapy, with a focus on three major strategies: chemical conjugation, self‐assembly of natural products, and codelivery of natural products with chemotherapeutic agents. We further discuss the major advantages of these systems, including improved bioavailability, enhanced targeting capacity, reduced off‐target toxicity, and the potential to overcome multidrug resistance. Finally, current challenges in formulation design, safety evaluation, large‐scale manufacturing, and clinical translation are highlighted. This review provides a comprehensive framework for the rational development of plant‐derived natural product nanomedicines in precision oncology.

Subjects

MeSH terms (MEDLINE)

Biological ProductsNeoplasmsAntineoplastic AgentsDrug Delivery SystemsAntineoplastic Agents, PhytogenicNanoparticle Drug Delivery SystemHumansNanomedicineAnimals

Author keywords

cancer treatmentnano‐delivery systemsplant‐derived natural productstargeted drug delivery

Substances

Biological ProductsAntineoplastic AgentsAntineoplastic Agents, PhytogenicNanoparticle Drug Delivery System

Authors and institutions

  • Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.

ORCID profiles: Qi Geng, Xiaojuan He, Cheng Lu

Cite

APA

Shi, C., Zhang, L., Yan, L., Geng, Q., Li, L., He, X., Zhao, N., Tan, Y., Zhang, X., & Lu, C. (2026). Plant‐Derived Natural Product Nanodelivery System in Cancer Therapy. Phytotherapy Research, 40(11), 6644-6669. https://doi.org/10.1002/ptr.70441

Vancouver

Shi C, Zhang L, Yan L, Geng Q, Li L, He X, et al. Plant‐Derived Natural Product Nanodelivery System in Cancer Therapy. Phytotherapy Research. 2026;40(11):6644-6669. doi:10.1002/ptr.70441

BibTeX
@article{Shi2026,
  author = {Shi, Changqi and Zhang, LuLu and Yan, Lan and Geng, Qi and Li, Li and He, Xiaojuan and Zhao, Ning and Tan, Yong and Zhang, Xiaomeng and Lu, Cheng},
  title = {Plant‐Derived Natural Product Nanodelivery System in Cancer Therapy},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6644--6669},
  doi = {10.1002/ptr.70441}
}
Start for free →